IL304142A - Condensed tetracyclic compounds, their compositions and uses - Google Patents
Condensed tetracyclic compounds, their compositions and usesInfo
- Publication number
- IL304142A IL304142A IL304142A IL30414223A IL304142A IL 304142 A IL304142 A IL 304142A IL 304142 A IL304142 A IL 304142A IL 30414223 A IL30414223 A IL 30414223A IL 304142 A IL304142 A IL 304142A
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- compounds
- fused
- fused quadracyclic
- quadracyclic compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021071062 | 2021-01-11 | ||
| PCT/US2022/011824 WO2022150707A1 (en) | 2021-01-11 | 2022-01-10 | Fused quadracyclic compounds, compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL304142A true IL304142A (en) | 2023-09-01 |
Family
ID=82356986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL304142A IL304142A (en) | 2021-01-11 | 2023-06-29 | Condensed tetracyclic compounds, their compositions and uses |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240140958A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4274833A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024504927A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230145335A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118574834A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022205678A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023013722A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3204167A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL304142A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023007992A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022150707A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3328394A4 (en) | 2015-07-30 | 2019-03-13 | ModernaTX, Inc. | CONCATEMEE peptide epitope RNAs |
| CN118290358A (zh) * | 2024-03-06 | 2024-07-05 | 江苏医药职业学院 | 一种制备利奈唑胺关键中间体(s)-5-((苄基氨基)甲基)噁唑烷-2-酮的方法 |
| WO2025219950A1 (en) | 2024-04-18 | 2025-10-23 | Astrazeneca Ab | Small molecule cx3cr1 modulators |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10059718B2 (en) * | 2016-01-04 | 2018-08-28 | Tabomedex Biosciences, LLC | Fused quadracyclic compounds, compositions and uses thereof |
-
2022
- 2022-01-10 BR BR112023013722A patent/BR112023013722A2/pt unknown
- 2022-01-10 AU AU2022205678A patent/AU2022205678A1/en active Pending
- 2022-01-10 US US18/270,616 patent/US20240140958A1/en active Pending
- 2022-01-10 JP JP2023541723A patent/JP2024504927A/ja active Pending
- 2022-01-10 CA CA3204167A patent/CA3204167A1/en active Pending
- 2022-01-10 CN CN202280017211.9A patent/CN118574834A/zh active Pending
- 2022-01-10 MX MX2023007992A patent/MX2023007992A/es unknown
- 2022-01-10 WO PCT/US2022/011824 patent/WO2022150707A1/en not_active Ceased
- 2022-01-10 KR KR1020237026555A patent/KR20230145335A/ko active Pending
- 2022-01-10 EP EP22737255.4A patent/EP4274833A4/en active Pending
-
2023
- 2023-06-29 IL IL304142A patent/IL304142A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230145335A (ko) | 2023-10-17 |
| US20240140958A1 (en) | 2024-05-02 |
| WO2022150707A1 (en) | 2022-07-14 |
| CN118574834A (zh) | 2024-08-30 |
| AU2022205678A1 (en) | 2023-08-03 |
| EP4274833A4 (en) | 2025-02-19 |
| JP2024504927A (ja) | 2024-02-02 |
| EP4274833A1 (en) | 2023-11-15 |
| MX2023007992A (es) | 2023-09-27 |
| CA3204167A1 (en) | 2022-07-14 |
| BR112023013722A2 (pt) | 2024-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285302A (en) | Compounds, preparations and methods | |
| IL285651A (en) | Anti-trem2 antibodies, preparations containing them and their uses | |
| IL284800A (en) | Methods, uses and compositions | |
| EP4256011C0 (en) | COMPOSITION | |
| GB202005911D0 (en) | Composition | |
| GB202004460D0 (en) | Herbical composition | |
| EP4274833A4 (en) | FUSED QUADRACYCLIC COMPOUNDS, COMPOSITIONS AND THEIR USES | |
| EP3746110A4 (en) | ETBR ANTAGONIST COMPOUNDS, COMPOSITIONS AND USES | |
| GB202012895D0 (en) | Composition | |
| GB202007377D0 (en) | Composition | |
| GB201915831D0 (en) | Compounds, compositions and therapeutic uses thereof | |
| IL287120A (en) | Compounds, preparations and methods | |
| PL4153603T3 (pl) | Kompozycje zawierające związki organosilanolowe i zastosowania | |
| GB202016236D0 (en) | Composition | |
| GB202006093D0 (en) | Composition | |
| GB201915828D0 (en) | Compounds, compositions and therapeutic uses thereof | |
| GB201915829D0 (en) | Compounds, compositions and therapeutic uses thereof | |
| EP4259762C0 (en) | COMPOSITION | |
| IL276125A (en) | Dihydroindolizinone derivative compounds, preparations containing them and their uses | |
| GB202000619D0 (en) | Composition | |
| EP4330363C0 (en) | COMPOSITION | |
| GB202013131D0 (en) | Pharamaceutical composition | |
| GB202014635D0 (en) | Composition | |
| GB2592952B (en) | Composition | |
| GB202305880D0 (en) | New compounds, uses and compositions |